Effect of cubeb in kidney disease
Phase 2
Completed
- Conditions
- Health Condition 1: - Health Condition 2: N183- Chronic kidney disease, stage 3 (moderate)
- Registration Number
- CTRI/2019/03/018200
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Known case / Newly diagnosed case of CKD stage 1-3, associated with Diabetes mellitus with treatment
Sr. Creatinine level � 6 mg/dl
GFR � 30ml/min/1.73m2(Cockroft-Gault equation)
Blood Urea level � 135mg/dl
Exclusion Criteria
CKD stage >3
Sr. Creatinine level > 6mg/
GFR < 30ml/min/1.73m2 (Cockroft-Gault equation)
Blood Urea level > 135mg/dl
H/O Metabolic disorders and systemic illness
H/O AIDS, T.B, Cancer, Mental disorders
Patients age below 20 and above 65 years
Pregnant and Lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in serum Creatinine level <br/ ><br> <br/ ><br>Blood Urea Level <br/ ><br> <br/ ><br>eGFR <br/ ><br> Urine-Routine and microscopy <br/ ><br>Timepoint: 42 days
- Secondary Outcome Measures
Name Time Method Reversal / Improvement of subjective parameterTimepoint: 42 days